{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:46:54Z","timestamp":1789184814388,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.lfs.2016.02.048","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T06:20:47Z","timestamp":1455344447000},"page":"154-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Therapeutic potential of chalcones as cardiovascular agents"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-0337","authenticated-orcid":false,"given":"Debarshi Kar","family":"Mahapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.02.048_bb0005","unstructured":"WHO Cardiovascular Data. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/ (accessed on July 2, 2015)."},{"key":"10.1016\/j.lfs.2016.02.048_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/b402985m","article-title":"Natural products to drugs: natural product derived compounds in clinical trials","volume":"22","author":"Butler","year":"2005","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.lfs.2016.02.048_bb0015","series-title":"Handbook of Nutraceuticals and Functional Foods","author":"Wildman","year":"2006"},{"key":"10.1016\/j.lfs.2016.02.048_bb0020","first-page":"104","article-title":"Anticancer potential of plants and natural products: a review","volume":"6","author":"Praksah","year":"2013","journal-title":"Am. J. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2016.02.048_bb0025","unstructured":"Flavonoids: flavones, flavonols, anthocyanins, and related compounds. www.life.illinois.edu\/ib\/425\/lecture11.html (accessed on July 5, 2015)."},{"issue":"5","key":"10.1016\/j.lfs.2016.02.048_bb0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/jphp.12032","article-title":"Cardioprotective effects of different flavonoids against myocardial ischaemia\/reperfusion injury in Langendorff-perfused rat hearts","volume":"65","author":"Testai","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2016.02.048_bb0035","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/0929867306666220401182509","article-title":"Bioactivities of chalcones","volume":"6","author":"Dimmock","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0040","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cber.18990320293","article-title":"Ueber die sechsisomeren Monoxybenzalacetophenone (Monoxychalkone)","volume":"32","author":"Kostanecki","year":"1899","journal-title":"Chemische Berichte"},{"key":"10.1016\/j.lfs.2016.02.048_bb0045","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.bmc.2009.10.002","article-title":"Natural and synthetic 2\u2032-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity","volume":"17","author":"Detsi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bmc.2007.10.006","article-title":"Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein","volume":"16","author":"Liu","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bmcl.2007.10.114","article-title":"Sulfonate chalcone as new class voltage-dependent K+ channel blocker","volume":"18","author":"Yarishkin","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.048_bb0060","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.bmcl.2005.08.039","article-title":"Synthesis and evaluation of antiplatelet activity of trihydroxy chalcone derivatives","volume":"15","author":"Zhao","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.048_bb0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2015.01.051","article-title":"Chalcones and their role in management of diabetes mellitus: structural and pharmacological perspectives","volume":"92","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","article-title":"Anti-cancer chalcones: structural and molecular target perspectives","volume":"98","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2016.02.048_bb0075","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1248\/bpb.29.1028","article-title":"Anti-angiogenic and anti-tumor activities of 2\u2032-hydroxy-4\u2032-methoxychalcone","volume":"29","author":"Lee","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2016.02.048_bb0080","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00044-011-9912-x","article-title":"Anti-HIV-1 and cytotoxicity studies of piperidyl-thienylchalcones and their 2-pyrazoline derivatives","volume":"21","author":"Rizvi","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.lfs.2016.02.048_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.molimm.2006.04.025","article-title":"Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-\u03baB nuclear translocation and I\u03ba-B phosphorylation in RAW 264.7 macrophage cells","volume":"44","author":"Israf","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.foodchem.2013.12.026","article-title":"Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC\u2013ESI MS\/MS and their xanthine oxidase inhibition","volume":"153","author":"Kim","year":"2014","journal-title":"Food Chem."},{"issue":"8","key":"10.1016\/j.lfs.2016.02.048_bb0095","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1271\/bbb.68.1706","article-title":"Anti-allergic activity of naringenin chalcone from a tomato skin extract","volume":"68","author":"Yamamoto","year":"2004","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0100","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/np800187f","article-title":"C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity","volume":"71","author":"Aoki","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2016.02.048_bb0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.phymed.2011.01.002","article-title":"Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies","volume":"18","author":"Birari","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2016.02.048_bb0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2013.04.026","article-title":"Coumarin chalcone fibrates: a new structural class of lipid lowering agents","volume":"64","author":"Sashidhara","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0115","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.bmc.2010.04.051","article-title":"Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth","volume":"18","author":"Mascarello","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejmech.2014.05.029","article-title":"Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi","volume":"81","author":"Sashidhara","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejmech.2014.10.036","article-title":"Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties","volume":"89","author":"Wang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejmech.2015.06.052","article-title":"Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives","volume":"101","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2016.02.048_bb0135","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/AAC.37.12.2550","article-title":"Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania","volume":"37","author":"Chen","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2016.02.048_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bioorg.2014.03.006","article-title":"Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor","volume":"54","author":"Abdullah","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2016.02.048_bb0145","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.ejmech.2007.12.027","article-title":"Antifungal activities of chalcones: a mechanistic study using various yeast strains","volume":"43","author":"Lahtchev","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0150","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejmech.2014.10.068","article-title":"Identification of quinoline-chalcone hybrids as potential antiulcer agents","volume":"89","author":"Sashidhara","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0024-3205(00)00974-7","article-title":"Chalcones are potent inhibitors of aromatase and 17 \u03b2-hydroxysteroid dehydrogenase activities","volume":"68","author":"Bail","year":"2001","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2016.02.048_bb0160","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2012.03.080","article-title":"Design, synthesis, and biological evaluation of chalcone oxime derivatives as potential immunosuppressive agents","volume":"22","author":"Luo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2016.02.048_bb0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2011.09.026","article-title":"Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects","volume":"413","author":"Cho","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2016.02.048_bb0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1472-8206.2008.00639.x","article-title":"Evaluation of chalcones-a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests","volume":"22","author":"Jamal","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2016.02.048_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1248\/bpb.30.145","article-title":"Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine","volume":"30","author":"Sato","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2016.02.048_bb0180","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/12040896","article-title":"4\u2032-Acetamidochalcone derivatives as potential antinociceptive agents","volume":"12","author":"de Campos-Buzzi","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2016.02.048_bb0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jcms.2013.07.020","article-title":"Osteogenic potential of a chalcone in a critical-size defect in calvaria rat","volume":"42","author":"Ortolan","year":"2014","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.lfs.2016.02.048_bb0190","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.bmcl.2010.01.113","article-title":"The synthesis and Angiotensin Converting Enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives","volume":"20","author":"Bonesi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.048_bb0195","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.ejmech.2010.05.054","article-title":"Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents","volume":"45","author":"Dong","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2016.02.048_bb0200","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jn\/134.6.1340","article-title":"The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells","volume":"134","author":"Casaschi","year":"2004","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.lfs.2016.02.048_bb0205","doi-asserted-by":"crossref","first-page":"683487","DOI":"10.1016\/S0031-9422(97)00157-X","article-title":"Xanthohumols, diacylglycerol acyltransferase inhibitors from Humulus lupulus","volume":"46","author":"Tabata","year":"1997","journal-title":"Phytochemistry"},{"key":"10.1016\/j.lfs.2016.02.048_bb0210","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.foodchem.2012.03.043","article-title":"Xanthohumol, a prenylated chalcone from Humulus lupulus L., inhibits cholesteryl ester transfer protein","volume":"134","author":"Hirata","year":"2012","journal-title":"Food Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0215","series-title":"Design, Synthesis and Biological Evaluation of Some Chalcone Derivatives as Potential Pancreatic Lipase Inhibitors","author":"Nguyen","year":"2013"},{"issue":"11","key":"10.1016\/j.lfs.2016.02.048_bb0220","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s12272-001-2126-x","article-title":"Bavachin and isobavachalcone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia","volume":"31","author":"Choi","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2016.02.048_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejmech.2014.04.085","article-title":"Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents","volume":"81","author":"Sashidhara","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.02.048_bb0230","series-title":"Davidson's Principles and Practice of Medicine","author":"Colledge","year":"2010"},{"key":"10.1016\/j.lfs.2016.02.048_bb0235","series-title":"Basic Pathology","author":"Kumar","year":"1992"},{"issue":"5","key":"10.1016\/j.lfs.2016.02.048_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jps.2600570502","article-title":"Electrolyte alterations in vascular smooth muscle and hypotensive activity of a new chalcone derivative","volume":"57","author":"Sherman","year":"1968","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2016.02.048_bb0245","series-title":"The Renin\u2013Angiotensin System: Current Research Progress in The Pancreas: The RAS in the Pancreas","author":"Leung","year":"2010"},{"key":"10.1016\/j.lfs.2016.02.048_bb0250","series-title":"Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy","author":"Golan","year":"2008"},{"key":"10.1016\/j.lfs.2016.02.048_bb0255","series-title":"Cardiovascular Endocrinology: Shared Pathways and Clinical Crossroads","first-page":"149","article-title":"Renin\u2013angiotensin system","author":"Kurukulasuriya","year":"2009"},{"key":"10.1016\/j.lfs.2016.02.048_bb0260","series-title":"Foye's Principles of Medicinal Chemistry","author":"Lemke","year":"2012"},{"key":"10.1016\/j.lfs.2016.02.048_bb0265","series-title":"Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry","author":"Beale","year":"2011"},{"key":"10.1016\/j.lfs.2016.02.048_bb0270","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1016\/j.bmc.2011.06.085","article-title":"Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors","volume":"19","author":"Kantevari","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.lfs.2016.02.048_bb0275","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3923\/pjbs.2013.1368.1372","article-title":"Synthesis and evaluation of chalcone based pyrimidines as angiotensin converting enzyme inhibitors","volume":"16","author":"Bukhari","year":"2013","journal-title":"Pak. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2016.02.048_bb0280","first-page":"785","article-title":"Hypotensive effects of safflower yellow in spontaneously hypertensive rats and influence on plasma renin activity and angiotensin II level","volume":"27","author":"Liu","year":"1992","journal-title":"Yao XueXueBao"},{"key":"10.1016\/j.lfs.2016.02.048_bb0285","series-title":"Katzung's Basic and Clinical Pharmacology","author":"Katzung","year":"2012"},{"key":"10.1016\/j.lfs.2016.02.048_bb0290","series-title":"Ganong's Review of Medical Physiology","author":"Barrett","year":"2010"},{"issue":"1","key":"10.1016\/j.lfs.2016.02.048_bb0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0149-2918(03)90007-5","article-title":"Effect of amlodipine on systolic blood pressure","volume":"25","author":"Levine","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2016.02.048_bb0300","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ardp.200800229","article-title":"Synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents","volume":"342","author":"Dong","year":"2009","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.lfs.2016.02.048_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ddr.1163","article-title":"Chalcones as potent antiplatelet agents and calcium channel blockers","volume":"53","author":"Lin","year":"2001","journal-title":"Drug Dev. Res."},{"issue":"10","key":"10.1016\/j.lfs.2016.02.048_bb0310","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1248\/cpb.41.1796","article-title":"Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca2+ antagonistic activity of tinctormine","volume":"41","author":"Meselhy","year":"1993","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.lfs.2016.02.048_bb0315","series-title":"Textbook of Medical Physiology","author":"Guyton","year":"2006"},{"key":"10.1016\/j.lfs.2016.02.048_bb0320","series-title":"Rang and Dell's Pharmacology","author":"Rang","year":"2008"},{"issue":"28","key":"10.1016\/j.lfs.2016.02.048_bb0325","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.2174\/092986710792231978","article-title":"Thromboxane synthase inhibitors and thromboxane A2 receptor antagonists: a quantitative structure activity relationships (QSARs) analysis","volume":"17","author":"Kontogiorgis","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2016.02.048_bb0330","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/157016112801784468","article-title":"Platelets in atherothrombosis- diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases","volume":"10","author":"Bigalke","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2016.02.048_bb0335","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.72.6.1194","article-title":"The biochemical pharmacology of thromboxane synthase inhibition in man","volume":"72","author":"Fitzgerald","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2016.02.048_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia","volume":"2","author":"Briere","year":"2007","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.lfs.2016.02.048_bb0345","series-title":"Modern Pharmacology with Clinical Applications","author":"Craig","year":"2004"},{"key":"10.1016\/j.lfs.2016.02.048_bb0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bmcl.2007.11.034","article-title":"2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies","volume":"18","author":"Meyers","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.048_bb0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11418-010-0410-0","article-title":"Effect of prenylated flavonoids and chalcones isolated from Artocarpus species on platelet aggregation in human whole blood","volume":"64","author":"Jantan","year":"2010","journal-title":"J. Nat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2016.02.048_bb0360","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1248\/bpb.b14-00099","article-title":"Chalcone derivatives inhibit human platelet aggregation and inhibit growth in human bladder cancer cells","volume":"37","author":"Wu","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2016.02.048_bb0365","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.bmc.2011.08.004","article-title":"Structure\u2013activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation","volume":"19","author":"Reddy","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2016.02.048_bb0370","first-page":"227","article-title":"The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit","volume":"77","author":"Fujita","year":"1992","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2016.02.048_bb0375","first-page":"696","article-title":"Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor","volume":"37","author":"Zang","year":"2002","journal-title":"Acta Pharmaceut."},{"issue":"8","key":"10.1016\/j.lfs.2016.02.048_bb0380","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/13880200500387406","article-title":"Antiplatelet effect of lonchocarpin and derricin isolated from Lonchocarpus sericeus","volume":"43","author":"Fontenele","year":"2005","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0385","article-title":"Effect of 17-methoxyl-7-hydroxyl-benzofuran chalcone on blood coagulation and platelet aggregation","author":"Qin","year":"2013","journal-title":"Chin. J. Exp. Trad. Med. Formul."},{"key":"10.1016\/j.lfs.2016.02.048_bb0390","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1211\/0022357044247","article-title":"Structure\u2013activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation","volume":"56","author":"Ko","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0395","series-title":"A Textbook of Clinical Pharmacology and Therapeutics","author":"Ritter","year":"2008"},{"key":"10.1016\/j.lfs.2016.02.048_bb0400","series-title":"Methods and Compositions for Treating Dyslipidemia. 20070218155 A1","author":"Kuhrts","year":"2007"},{"key":"10.1016\/j.lfs.2016.02.048_bb0405","series-title":"Harper's Illustrated Biochemistry","author":"Murray","year":"2003"},{"issue":"7","key":"10.1016\/j.lfs.2016.02.048_bb0410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ajcn\/20.7.777","article-title":"Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels","volume":"20","author":"Hollister","year":"1967","journal-title":"Am. J. Clin. Nutr."},{"issue":"10","key":"10.1016\/j.lfs.2016.02.048_bb0415","first-page":"836","article-title":"DGAT inhibitors for obesity","volume":"8","author":"Matsuda","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2016.02.048_bb0420","unstructured":"Mammalian diacylglycerol acyltransferases (DGAT) http:\/\/lipidlibrary.aocs.org\/animbio\/dgat\/index.htm (accessed on July19, 2015)."},{"key":"10.1016\/j.lfs.2016.02.048_bb0425","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/01.ATV.20.9.2029","article-title":"CETP and atherosclerosis","volume":"20","author":"Barter","year":"2000","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2016.02.048_bb0430","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0435","first-page":"897","article-title":"Inhibitors of pancreatic lipase: state of the art and clinical perspectives","volume":"13","author":"Lunagariya","year":"2014","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.lfs.2016.02.048_bb0440","first-page":"E1","article-title":"Acyl-coenzyme A: cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am. J. Physiol. Endoc. M."},{"key":"10.1016\/j.lfs.2016.02.048_bb0445","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-2275(20)34322-4","article-title":"Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism","volume":"26","author":"Suckling","year":"1985","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.lfs.2016.02.048_bb0450","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/clp.12.55","article-title":"Nutaceuticals with lipid lowering activity: do they have any effect beyond cholesterol reduction","volume":"7","author":"Cicero","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0455","series-title":"Goodman & Gilman's Manual of Pharmacology and Therapeutics","author":"Brunton","year":"2008"},{"key":"10.1016\/j.lfs.2016.02.048_bb0460","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1016\/j.bmcl.2011.03.057","article-title":"Synthesis and antidyslipidemic activity of chalcone fibrates","volume":"11","author":"Shukla","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2016.02.048_bb0465","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11745-013-3824-0","article-title":"Antidyslipidemic and antioxidant effects of novel lupeol-derived chalcones","volume":"48","author":"Srivastava","year":"2013","journal-title":"Lipids"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2016.02.048_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1440-1681.2005.04147.x","article-title":"Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats","volume":"32","author":"Ogawa","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2016.02.048_bb0475","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1440-1681.2007.04578.x","article-title":"Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats","volume":"34","author":"Ogawa","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0480","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ardp.200600034","article-title":"Biological evaluation of chalcones and analogues as hypolipidemic agents","volume":"339","author":"Santos","year":"2006","journal-title":"Arch. Pharm. Chem. Life Sci."},{"issue":"828","key":"10.1016\/j.lfs.2016.02.048_bb0485","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/pgmj.70.828.767","article-title":"Cardioprotective therapeutics \u2014 drugs used in hypertension, hyperlipidemia, thromboembolization, arrhythmias, postmenopausal state and as anti-oxidants","volume":"70","author":"Jolobe","year":"1994","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.lfs.2016.02.048_bb0490","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/IJMR.2010_132_05_608","article-title":"The cardio-protective diet","volume":"132","author":"Sivasankaran","year":"2010","journal-title":"Indian J. Med. Res."},{"issue":"14","key":"10.1016\/j.lfs.2016.02.048_bb0495","first-page":"191","article-title":"Natural polyphenols and cardioprotection","volume":"11","author":"Lecour","year":"2011","journal-title":"Mini-Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2016.02.048_bb0500","first-page":"110","article-title":"Cardioprotective activity of chalcones in ischemia\/reperfusion-induced myocardial infarction in albino rats","volume":"17","author":"Annapurna","year":"2012","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.lfs.2016.02.048_bb0505","article-title":"The cardioprotective effect of 17-methoxyl-7-hydroxyl-benzofuran chalcone in rats with myocardial ischemia reperfusion injury","author":"Qin","year":"2012","journal-title":"Chin. J. Biochem. Pharmaceut."},{"key":"10.1016\/j.lfs.2016.02.048_bb0510","unstructured":"Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. http:\/\/lsp.nwsuaf.edu.cn\/tcmsp.php (accessed on January 11, 2016)."},{"key":"10.1016\/j.lfs.2016.02.048_bb0515","series-title":"Encyclopedia of Traditional Chinese Medicines \u2014 Molecular Structures, Pharmacological Activities, Natural Sources and Applications","author":"Zhou","year":"2011"},{"key":"10.1016\/j.lfs.2016.02.048_bb0520","series-title":"Dictionary of Flavonoids with CD-ROM","author":"Buckingham","year":"2015"},{"key":"10.1016\/j.lfs.2016.02.048_bb0525","series-title":"Dictionary of Food Compounds with CD-ROM","author":"Yannai","year":"2012"},{"key":"10.1016\/j.lfs.2016.02.048_bb0530","series-title":"Studies in Natural Products Chemistry: Bioactive Natural Products","author":"Atta-ur-Rahman","year":"2005"},{"key":"10.1016\/j.lfs.2016.02.048_bb0535","unstructured":"Combined Chemical Dictionary. http:\/\/ccd.chemnetbase.com\/dictionary-search.do?method=view&id=11447924&si (accessed on January 13, 2016)."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:05:21Z","timestamp":1748775921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516300984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":107,"alternative-id":["S0024320516300984"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.048","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of chalcones as cardiovascular agents","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}